Multi-epitope Folate Receptor Alpha Peptide Vaccine, GM-CSF, and Cyclophosphamide in Treating Patients With Triple Negative Breast Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Kathryn J Ruddy
Academic and Community Cancer Research United
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
12 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Mayo Clinic in Arizona
Scottsdale, Arizona, United States
- City of Hope Comprehensive Cancer Center
Duarte, California, United States
- Mayo Clinic in Florida
Jacksonville, Florida, United States
- University of Miami Miller School of Medicine-Sylvester Cancer Center
Miami, Florida, United States
- University of Chicago Comprehensive Cancer Center
Chicago, Illinois, United States
- Carle Cancer Center Nci Community Oncology Research Program
Urbana, Illinois, United States
- Ochsner Medical Center Jefferson
New Orleans, Louisiana, United States
- Dana-Farber Cancer Institute
Boston, Massachusetts, United States
- Massachusetts General Hospital Cancer Center
Boston, Massachusetts, United States
- Mayo Clinic in Rochester
Rochester, Minnesota, United States
- Inova Fairfax Hospital
Falls Church, Virginia, United States
- Marshfield Medical Center-Marshfield
Marshfield, Wisconsin, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Mar 2017
- Primary completion
- 28 Feb 2025
- Completion
- 31 Jul 2026
- Last update posted
- 30 Jun 2026
- Registered enrollment
- 280
- Registry id
- NCT03012100
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.